Vazzano Joseph Walter
- SEC CIK
- 0001715291
In the past year, 6 open-market sale filings worth $598.7K and no purchases.
Current role at each company
- ABEO Abeona Therapeutics Inc.Chief Financial Officeras of Sep 29, 2026
- ALLR Allarity Therapeutics, Inc.Directoras of Jan 24, 2025
- ATXI Avenue Therapeutics, Inc.Chief Financial Officeras of Dec 20, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $598.7K
- 6 filings
- Net
- −$598.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vazzano Joseph Walter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ABEO Abeona Therapeutics Inc.
Chief Financial Officer14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Vazzano Joseph WalterChief Financial Officer | PPurchase | +2.50K | $4.00 | +$10.0K | +2.7%95.3K after | |
| Sep 20, 2023 (view filing) | Sep 19 | 1 day | Vazzano Joseph WalterChief Financial Officer | PPurchase | +3.00K | $3.82 | +$11.5K | +1.3%238.2K after | 2 lots |
| Apr 26, 2024 (view filing) | Apr 25 | 1 day | Vazzano Joseph WalterChief Financial Officer | PPurchase | +5.61K | $3.14 | +$17.6K | +2.5%233.9K after | |
| Jun 6, 2025 (view filing) | Jun 6 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −17.8K | $6.76 | −$120.3K | −3.5%491.2K after | |
| Jul 10, 2025 (view filing) | Jul 9 | 1 day | Vazzano Joseph WalterChief Financial Officer | SSale | −25.4K | $5.86 | −$148.9K | −5.0%479.2K after | |
| Jul 22, 2025 (view filing) | Jul 22 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −1.50K | $6.64 | −$9.97K | −0.3%477.7K after | |
| Aug 15, 2025 (view filing) | Aug 15 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −15.0K | $7.36 | −$110.4K | −3.1%462.7K after | |
| Oct 1, 2025 (view filing) | Sep 29 | 2 days | Vazzano Joseph WalterChief Financial Officer | SSale | −9.04K | $5.39 | −$48.7K | −2.0%453.6K after | |
| Jan 22, 2026 (view filing) | Jan 22 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −18.7K | $5.33 | −$99.5K | −3.2%568.6K after | |
| Mar 16, 2026 (view filing) | Mar 16 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −785 | $4.76 | −$3.74K | −0.1%567.8K after |
ATXI Avenue Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 (view filing) | Sep 15 | Same day | Vazzano Joseph WalterChief Financial Officer | SSale | −7.16K | $1.62 | −$11.6K | −9.9%65.3K after |